Published: May 2, 2026 Reading Time: 7 minutes
While the dairy sector remains volatile (Fonterra’s latest farmgate milk price forecast sits at $8.50/kg MS), the magazine points to surprising resilience in and aquaculture . “Investors have been hiding in utilities and property for two years,” Wills writes. “Issue 046 argues that the rotation has begun. Look at cyclicals, but be selective.” A centerpiece chart tracks the divergence between listed infrastructure (down 2% YTD) and discretionary retail (up 11% YTD), suggesting that the Kiwi consumer is cautiously opening their wallet again. Feature Interview: The CEO of Fisher & Paykel Healthcare One of the most anticipated segments of any NZX Magazine issue is the one-on-one CEO interview. For Issue 046 , the editors secured an exclusive sit-down with Lewis Gradon of Fisher & Paykel Healthcare (FPH).
FPH is pivoting hard into home-based respiratory care . Gradon notes that 60% of their R&D budget is now devoted to miniaturization for home use, a direct result of the "hospital-at-home" trend that survived COVID. Deep Dive: The Carbon Credit Conundrum Page 42 of Issue 046 features a sobering analysis of the New Zealand Emissions Trading Scheme (NZ ETS) by Dr. Rangi Mātātā , an environmental economist.
Published: May 2, 2026 Reading Time: 7 minutes
While the dairy sector remains volatile (Fonterra’s latest farmgate milk price forecast sits at $8.50/kg MS), the magazine points to surprising resilience in and aquaculture . “Investors have been hiding in utilities and property for two years,” Wills writes. “Issue 046 argues that the rotation has begun. Look at cyclicals, but be selective.” A centerpiece chart tracks the divergence between listed infrastructure (down 2% YTD) and discretionary retail (up 11% YTD), suggesting that the Kiwi consumer is cautiously opening their wallet again. Feature Interview: The CEO of Fisher & Paykel Healthcare One of the most anticipated segments of any NZX Magazine issue is the one-on-one CEO interview. For Issue 046 , the editors secured an exclusive sit-down with Lewis Gradon of Fisher & Paykel Healthcare (FPH).
FPH is pivoting hard into home-based respiratory care . Gradon notes that 60% of their R&D budget is now devoted to miniaturization for home use, a direct result of the "hospital-at-home" trend that survived COVID. Deep Dive: The Carbon Credit Conundrum Page 42 of Issue 046 features a sobering analysis of the New Zealand Emissions Trading Scheme (NZ ETS) by Dr. Rangi Mātātā , an environmental economist.